methotrexate has been researched along with Anaplastic Large-Cell Lymphoma in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (30.77) | 18.2507 |
| 2000's | 12 (23.08) | 29.6817 |
| 2010's | 17 (32.69) | 24.3611 |
| 2020's | 7 (13.46) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuhara, N; Furukawa, E; Harigae, H; Ichikawa, S; Ichinohasama, R; Miyazaki, M; Onishi, Y; Onodera, K; Yokoyama, H | 1 |
| Abe, M; Fujii, S; Harada, T; Kagawa, K; Maruhashi, T; Matsudate, Y; Miki, H; Mizuguchi, M; Nakamura, M; Nakamura, S; Oura, M; Sogabe, K; Sumitani, R; Takahashi, M; Uehara, H; Yada, M | 1 |
| Chen, K; Ding, T; Guan, M; Ruan, H; Tang, X; Wang, Z; Zhang, C | 1 |
| Funakoshi-Tago, M; Komori, R; Tago, K; Tamura, H; Uchihara, Y | 1 |
| Banavali, SD; Gujral, S; Kembhavi, S; Narula, G; Phillip, D; Pradhan, ND; Prasad, M; Shah, S; Shet, T; Sridhar, E; Vijayasekharan, K | 1 |
| Hirano, Y; Ikemura, M; Kurokawa, M; Miyawaki, S; Nakatomi, H; Saito, N; Satou, M; Takayanagi, S; Tanaka, R; Tanaka, S; Taoka, K; Toyama, K | 1 |
| Al-Maghraby, H; Al-Mansour, M; Shirah, B | 1 |
| Kawano, Y; Kodama, Y; Kusuda, M; Mitsunobu, T; Nakagawa, S; Nishikawa, T; Okamoto, Y | 1 |
| Brugières, L; Le Deley, MC; Marky, I; Mori, T; Reiter, A; Rosolen, A; Uyttebroeck, A; Williams, D; Woessman, W; Wrobel, G; Zsiros, J | 1 |
| Hosokawa, Y; Ishikawa, E; Koura, A; Kubota, Y; Moriue, J; Moriue, T; Nakai, K; Tamai, A; Yokoi, I; Yoneda, K | 1 |
| Jin, J; Marginean, EC; Saloojee, N; Shukla, T | 1 |
| Antony, PT; Basu, D; Negi, VS; Singh, BK; Verma, SK | 1 |
| Gurung, D; Kempf, W; Parajuli, S; Paudel, U; Pokhrel, DB | 1 |
| Furuya, K; Nakagomi, T; Ogawa, A; Takahashi, Y; Takanashi, S | 1 |
| Alexander, S; Chang, M; Gross, TG; Kinney, MC; Kraveka, JM; Laver, J; Lowe, E; Lynch, JC; Perkins, SL; Smith, L; Weinstein, H; Weitzman, S | 1 |
| Acebo-Mariñas, E; Aperribay-Esparza, A; de Quintana-Sancho, A; Gardeazabal-García, J | 1 |
| Carrillo-Guijón, R; Hermosa-Zarza, E; Jaén-Olasolo, P; Perez-Gala, S; Turrión-Merino, L; Urech-García-de-la-Vega, M | 1 |
| Alaibac, M; D'Amore, ES; Ferrazzi, A; Russo, I | 1 |
| Dzhulakian, UL; Egorova, EK; Giliazitdinova, EA; Gorgidze, LA; Kaplanskaia, IB; Krasil'nikova, BB; Kravchenko, SK; Kremenetskaia, AM; Lutsenko, IN; Magomedova, AU; Mar'in, DS; Margolin, OV; Ryzhikova, NA; Samoĭlova, RS; Valiev, TT; Vinogradova, IuE; Vorob'ev, AI; Vorob'ev, IA; Zvonkov, EE | 1 |
| Boccalatte, FE; Bosia, A; Cheng, M; Chiarle, R; Comb, MJ; D'Amico, L; Goss, VL; Inghirami, G; Jensen, ON; Lee, K; Nardone, J; Polakiewicz, RD; Riera, L; Riganti, C; Ruggeri, B; Rush, J; Voena, C | 1 |
| Guan, ZZ; Lin, H; Ling, JY; Luo, WB; Peng, RJ; Sun, XF; Xia, Y; Xiang, XJ; Zhen, ZJ; Zheng, L | 1 |
| Abla, O; Chong, AL; Ngan, BY; Weitzman, S | 1 |
| Loeffler, M; Pfreundschuh, M; Schmitz, N; Zeynalova, S | 1 |
| Bes, C; Bes, ZS; Soy, M; Vardı, S | 1 |
| Edwards, MS; Fairbank, J; Midgely, P | 1 |
| Hilliard, LM; Kelly, DR; Nabors, LB; Oakes, WJ; Reddy, AT; Shah, AC | 1 |
| Brugières, L; Horibe, K; Le Deley, MC; Mauguen, A; Reiter, A; Rosolen, A; Williams, D; Wrobel, G | 1 |
| Brugières, L; d'Amore, E; Delsol, G; Fraga, M; Klapper, W; Lamant, L; Le Deley, MC; Maldyk, J; Mauguen, A; McCarthy, K; Nakagawa, A; Oschlies, I; Simonitsch-Klupp, I | 1 |
| Ferreri, AJ; Govi, S; Pileri, SA; Savage, KJ | 1 |
| Catalano, PJ; Halasz, LM; Jacene, HA; Lacasce, A; Mauch, PM; Ng, AK; Van den Abbeele, AD | 1 |
| Hobson, R; Morland, B; Ng, A; Williams, D | 1 |
| Jun, JB; Kim, IS; Kim, SK | 1 |
| Blume, JE; Cheney, RT; Stoll, HL | 1 |
| AlKindi, S; Dennison, D; Pathare, AV; Rao, TV; Rehman, JU | 1 |
| Jain, S; Mandal, S; Varma, K | 1 |
| Amadori, S; Baroni, CD; Bocchia, M; Falini, B; Gherlinzoni, F; Martelli, M; Mazza, P; Pileri, S; Poggi, S; Sabattini, E | 1 |
| Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW | 1 |
| Anderson, JR; Cecalupo, AJ; Finlay, JL; Hutchinson, RJ; Kadin, ME; Kjeldsberg, CR; Meadows, AT; Provisor, AJ; Woods, WG | 1 |
| Christensen, HK; Thomsen, K; Vejlsgaard, GL | 1 |
| Gaubert, I; Gladieff, L; Hoerni, B; Huguet, F; Michel, G; Pein, F; Robert, A; Rochaix, P; Rubie, H; Sommelet, D | 1 |
| Baccarini, M; Barillari, G; Biffoni, F; Buffoli, A; Cerno, M; Damiani, D; Fanin, R; Geromin, A; Infanti, L; Rinaldi, C; Savignano, C; Silvestri, F; Zaja, F | 1 |
| Kadin, ME; Sajjadian, A; Vonderheid, EC | 1 |
| Amadori, S; Bendandi, M; Falini, B; Gherlinzoni, F; Mandelli, F; Martelli, M; Martelli, MF; Pileri, SA; Sabattini, E; Tura, S; Zinzani, PL | 1 |
| Atsumi, M; Hayashi, K; Konishi, Y; Maruyama, H; Nakatsuji, N; Shimamoto, K; Sugihara, S; Tsutsumi, M | 1 |
| Aydemir, U; Bierwolf, S; Brittinger, G; Engelhard, M; Gerhartz, HH; Griesser, H; Huhn, D; Lennert, K; Meusers, P; Siegert, W; Thiel, E; Tiemann, M; Wilmanns, W | 1 |
| Baccarani, M; Barillari, G; Cerno, M; Damiani, D; Fanin, R; Geromin, A; Infanti, L; Rinaldi, C; Savignano, C; Silvestri, F; Zaja, F | 1 |
| Amendola, A; Bendandi, M; Bocchia, M; Cantonetti, M; De Renzo, A; Falini, B; Gherlinzoni, F; Gobbi, M; Magagnoli, M; Mandelli, F; Marra, R; Martelli, M; Mazza, P; Moretti, L; Pavone, E; Pileri, SA; Ronconi, F; Sabattini, E; Tura, S; Zaccaria, A; Zinzani, PL | 1 |
| Brugières, L; Deley, MC; Delsol, G; Devalck, C; Hartmann, O; Leverger, G; Meguerian-Bedoyan, Z; Pacquement, H; Pondarré, C; Robert, A; Rodary, C; Terrier-Lacombe, MJ | 1 |
| Boerman, RH; Mattijssen, V; Mulder, AH; Raemaekers, JM | 1 |
| Baccarani, M; Cerno, M; Damiani, D; Fanin, R; Geromin, A; Infanti, L; Patriarca, F; Silvestri, F; Sperotto, A; Stocchi, R; Zaja, F | 1 |
| Maeda, SA; Pereira, EM; Reis-Filho, JS | 1 |
| Gerrard, M; Hobson, R; Imeson, J; McCarthy, K; Pinkerton, CR; Williams, DM | 1 |
5 review(s) available for methotrexate and Anaplastic Large-Cell Lymphoma
| Article | Year |
|---|---|
Anaplastic large cell lymphoma in a patient with systemic onset juvenile arthritis: case report and review of literature.
Topics: Arthritis, Juvenile; Biopsy; Fatal Outcome; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Time Factors; Tomography, X-Ray Computed; Young Adult | 2014 |
Anaplastic large cell lymphoma, ALK-positive.
Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Prednisolone; Prednisone; Receptor Protein-Tyrosine Kinases; Stem Cell Transplantation; T-Lymphocytes; Translocation, Genetic; Vincristine | 2012 |
Anaplastic large cell lymphoma of bone--is it a bad tumor?
Topics: Activin Receptors, Type II; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Male; Methotrexate; Prognosis; Remission Induction; Scapula; Treatment Outcome; United Kingdom | 2007 |
Anaplastic Ki-1-positive large cell lymphoma of the pancreas: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Middle Aged; Pancreatic Neoplasms; Peplomycin; Prednisolone; Vincristine | 1997 |
Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Prednisolone; Recurrence; Risk; Thioguanine; United Kingdom; Vincristine | 2002 |
11 trial(s) available for methotrexate and Anaplastic Large-Cell Lymphoma
| Article | Year |
|---|---|
Central nervous system involvement in anaplastic large cell lymphoma in childhood: results from a multicentre European and Japanese study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Europe; Follow-Up Studies; Humans; Japan; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Survival Rate | 2013 |
Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Doxorubicin; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Large-Cell, Anaplastic; Male; Mercaptopurine; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Survival Rate; Vinblastine; Vincristine; Young Adult | 2014 |
[Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Leukopenia; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Staging; Remission Induction; Stem Cell Transplantation; Thrombocytopenia; Vincristine; Vindesine | 2009 |
Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Humans; Infant; Injections, Spinal; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Risk Assessment; Risk Factors; Survival Rate; Treatment Outcome; Vinblastine; Young Adult | 2011 |
Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study.
Topics: Adolescent; Adult; Anaplastic Lymphoma Kinase; Biomarkers, Tumor; Child; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 5; Female; Humans; Immunophenotyping; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Phenotype; Prognosis; Receptor Protein-Tyrosine Kinases; Translocation, Genetic; Vinblastine; Young Adult | 2011 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors | 1995 |
Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Humans; Hydrocortisone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 1994 |
Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Phenotype; Prednisone; Prospective Studies; Recurrence; Survival Rate; Vincristine | 1996 |
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1997 |
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Male; Mediastinum; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vinblastine; Vincristine | 1998 |
CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Child; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 5; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; France; Humans; Immunophenotyping; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Prednisone; Prognosis; Protein-Tyrosine Kinases; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Survival Rate; Translocation, Genetic; Treatment Outcome; Vinblastine; Vincristine | 1998 |
36 other study(ies) available for methotrexate and Anaplastic Large-Cell Lymphoma
| Article | Year |
|---|---|
Long-term remission of primary refractory ALK-positive anaplastic large cell lymphoma after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Brentuximab Vedotin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Recurrence, Local; Receptor Protein-Tyrosine Kinases | 2022 |
[Primary cutaneous anaplastic large cell lymphoma with systemic progression responding to low-dose methotrexate therapy].
Topics: Aged; Humans; Immunotherapy; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Lymphomatoid Papulosis; Male; Methotrexate; Skin Neoplasms | 2022 |
The characteristics of cerebrospinal fluid anaplastic large cells in a patient with primary leptomeningeal anaplastic large cell lymphoma.
Topics: Headache; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Receptor Protein-Tyrosine Kinases | 2022 |
Methotrexate significantly induces apoptosis by inhibiting STAT3 activation in NPM-ALK-positive ALCL cells.
Topics: Anaplastic Lymphoma Kinase; Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Humans; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Mice; STAT3 Transcription Factor | 2019 |
Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Humans; India; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Vinblastine | 2020 |
Small Cell Variant of Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma of the Dura Mimicking Tentorial Meningioma.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Cytarabine; Diagnosis, Differential; Etoposide; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Meningeal Neoplasms; Meningioma; Methotrexate; Supratentorial Neoplasms | 2020 |
Transformation of Grade I Follicular Lymphoma to Anaplastic Large Cell Lymphoma CD30+ ALK1- with Complete Response to Brentuximab Vedotin and High-Dose Methotrexate.
Topics: Adult; Antineoplastic Agents, Immunological; Brentuximab Vedotin; Humans; Lymphoma, Follicular; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Grading | 2020 |
Brentuximab Vedotin and High-dose Methotrexate Administrated Alternately for Refractory Anaplastic Large-cell Lymphoma With Central Nervous System Disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Central Nervous System Diseases; Child; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis | 2020 |
Successful treatment of primary cutaneous anaplastic large cell lymphoma with intralesional methotrexate therapy.
Topics: Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy; Female; Humans; Immunohistochemistry; Injections, Intralesional; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Skin Neoplasms; Treatment Outcome | 2014 |
Anaplastic large cell lymphoma of the colon in a patient with colonic Crohn disease treated with infliximab and methotrexate.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Middle Aged; Time Factors; Treatment Outcome | 2014 |
Primary cutaneous CD30-positive anaplastic large cell lymphoma in an 80-year-old man: a case report from Nepal.
Topics: Aged, 80 and over; Dermatologic Agents; Humans; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Male; Methotrexate; Nepal; Skin Neoplasms | 2014 |
High-dose methotrexate monotherapy followed by radiation for CD30-positive, anaplastic lymphoma kinase-1-positive anaplastic large-cell lymphoma in the brain of a child.
Topics: Anaplastic Lymphoma Kinase; Antimetabolites, Antineoplastic; Biopsy; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Cranial Irradiation; Decompression, Surgical; Disease-Free Survival; Drug Administration Schedule; Humans; Immunohistochemistry; Intracranial Hypertension; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Male; Methotrexate; Radiotherapy, Adjuvant; Receptor Protein-Tyrosine Kinases; Treatment Outcome | 2014 |
Cerebral involvement as the first extracutaneous manifestation of mycosis fungoides.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Brain; Carmustine; Combined Modality Therapy; Cytarabine; Disease Progression; Fatal Outcome; Female; Humans; Lymphoma, Large-Cell, Anaplastic; Memory Disorders; Methotrexate; Middle Aged; Mycosis Fungoides; Nystagmus, Pathologic; PUVA Therapy; Skin Neoplasms; Tetrahydronaphthalenes | 2015 |
Primary cutaneous CD30+ anaplastic large cell lymphoma treated with radiotherapy and methotrexate with development of xanthomas at the sites of prior disease.
Topics: Eyelid Neoplasms; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Radiotherapy; Xanthomatosis | 2016 |
A Case of Angioinvasive Cutaneous Anaplastic Large Cell Lymphoma Completely Regressed After Low-dose Systemic Methotrexate.
Topics: Aged; Antimetabolites, Antineoplastic; Blood Vessels; Female; Humans; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Neoplasm Invasiveness; Skin Neoplasms | 2017 |
[Efficacy of therapy of different variants of anaplastic large T-cell lymphomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Treatment Outcome; Vincristine | 2008 |
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
Topics: Amino Acid Sequence; Antimetabolites, Antineoplastic; Carbazoles; Cell Adhesion Molecules; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Hydroxymethyl and Formyl Transferases; Indazoles; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Microfilament Proteins; Molecular Sequence Data; Multienzyme Complexes; Neoplasm Proteins; Nucleotide Deaminases; Phenylurea Compounds; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Interaction Mapping; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Transcription, Genetic | 2009 |
Anaplastic large cell lymphoma of the ovary in a pediatric patient.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Female; Humans; Long QT Syndrome; Lymph Node Excision; Lymphoma, Large-Cell, Anaplastic; Mercaptopurine; Methotrexate; Omentum; Ovarian Neoplasms; Ovariectomy; Postoperative Complications; Prednisone; Remission Induction; Sepsis; Tumor Lysis Syndrome; Vincristine | 2009 |
Response: Intrathecal methotrexate and central nervous system events.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Immunotherapy; Injections, Spinal; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Prednisone; Prognosis; Research Design; Risk; Treatment Outcome; Vincristine | 2009 |
Anaplastic large cell lymphoma in a patient with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate | 2011 |
Anaplastic large cell Ki-1 lymphoma arising in bone.
Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Humans; Hydrocortisone; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Male; Methotrexate; Prednisolone; Radiography; Thoracic Vertebrae; Treatment Outcome; Vincristine | 1993 |
Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients.
Topics: Adolescent; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Immunocompetence; Infant; Lymphoma, B-Cell; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Treatment Outcome | 2010 |
Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Rituximab; Treatment Failure; Vincristine; Young Adult | 2012 |
Anaplastic large cell lymphoma in a patient with rheumatoid arthritis taking low dose methotrexate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Follow-Up Studies; Humans; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Middle Aged; Remission Induction; Time Factors; Treatment Outcome | 2006 |
Treatment of primary cutaneous CD30+ anaplastic large cell lymphoma with intralesional methotrexate.
Topics: Antimetabolites, Antineoplastic; Female; Humans; Injections, Intralesional; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Middle Aged; Treatment Outcome | 2006 |
Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma.
Topics: Adult; Albendazole; Anthelmintics; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Cyclophosphamide; Cytomegalovirus Infections; Doxorubicin; Endemic Diseases; Ganciclovir; Gastritis; Humans; Immunocompromised Host; Immunosuppressive Agents; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Oman; Prednisolone; Prednisone; Remission Induction; Strongyloidiasis; Vincristine | 2007 |
Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Fine-Needle; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Mitoguazone; Neoplasm Recurrence, Local; Prednisone; Skin Neoplasms; Vincristine | 2008 |
Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 cases.
Topics: Adolescent; Adult; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Ki-1 Antigen; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1994 |
Lymphomatoid papulosis: a follow-up study of 41 patients.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Lymphomatoid Papulosis; Male; Methotrexate; Middle Aged; PUVA Therapy | 1994 |
Childhood anaplastic large cell lymphoma Ki-1/CD30: clinicopathologic features of 19 cases.
Topics: Adolescent; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Female; Histiocytic Sarcoma; Humans; Immunoenzyme Techniques; Immunophenotyping; Infant; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Staging; Prednisone; Receptors, Interleukin-2; Remission Induction; Retrospective Studies; Treatment Outcome; Vincristine | 1994 |
Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Prednisone; Time Factors; Vincristine | 1996 |
Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anemia; Antimetabolites, Antineoplastic; Aspartate Aminotransferases; Dermatologic Agents; Diarrhea; Drug Administration Schedule; Fatigue; Female; Follow-Up Studies; Humans; Ki-1 Antigen; Liver Cirrhosis; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Lymphomatoid Papulosis; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Nausea; Remission Induction; Skin Diseases; Skin Neoplasms; Weight Loss | 1996 |
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 1997 |
Downbeat nystagmus caused by thiamine deficiency: an unusual presentation of CNS localization of large cell anaplastic CD 30-positive non-Hodgkin's lymphoma.
Topics: Adult; Anisocoria; Antineoplastic Combined Chemotherapy Protocols; Aphasia; Bleomycin; Brain Neoplasms; Cyclophosphamide; Cytarabine; Dizziness; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hemiplegia; Humans; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Mitoxantrone; Neoplastic Stem Cells; Nystagmus, Pathologic; Prednisone; Remission Induction; Thiamine; Vincristine; Vomiting; Wernicke Encephalopathy | 1999 |
The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: results of 40 cases treated in a single center.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Prednisone; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Vincristine | 1999 |
Sarcomatoid variant of anaplastic large cell lymphoma mimicking a primary breast cancer: a challenging diagnosis.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Fatal Outcome; Female; Humans; Ki-1 Antigen; Leukocyte Common Antigens; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Prednisolone; Sarcoma; Vimentin; Vincristine | 2002 |